热门资讯> 正文
2025-08-08 04:45
Skye Bioscience (NASDAQ: SKYE) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate of $(0.31) by 40.58 percent. This is a 120 percent decrease over losses of $(0.20) per share from the same period last year.